1. Testa F, Rossi S, Colucci R, Gallo B, Di Iorio V, della Corte M, et al. Macular abnormalities in Italian patients with retinitis pigmentosa. Br J Ophthalmol.2014;98:946-50.
2. Onakpoya OH, Adeoti CO, Oluleye TS,Ajayi IA, Majengbasan T, Olorundare OK, et al. Clinical presentation and visual status of retinitis pigmentosa patients: a multicenter study in southwestern nigeria. Clin Ophthalmol.2016;10:1579-83.
3. Vezinaw CM, Fishman GA, McAnany JJ. VISUAL IMPAIRMENT IN RETINITIS PIGMENTOSA. Retina. 2019;Sep 23.
4. Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res.2018; 66:157-186.
5. Liew G, Strong S, Bradley P, Severn P, Moore AT, Webster AR, et al. Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa. Br J Ophthalmol.2019;103:1163-66.
6. Hajali M, Fishman GA, Anderson RJ. The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol.2008;92:1065-8.
7. Hajali M, Fishman GA. The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond).2009;23:915-9.
8. Liew G, Moore AT, Bradley PD, Webster AR, Michaelides M, et al. Factors associated with visual acuity in patients with cystoid macular oedema and Retinitis Pigmentosa. Ophthalmic Epidemiol.2018;25:183-186.
9. Miyata M, Oishi A, Oishi M, Hasegawa T, Ikeda HO, Tsujikawa A. Long-term efficacy and safety of anti-VEGF therapy in retinitis pigmentosa: a case report. BMC Ophthalmol.2018;18:248.
10.Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual Acuities "Hand Motion" and "Counting Fingers" Can Be Quantified With the Freiburg Visual Acuity Test. Invest Ophthalmol Vis Sci. 2006;47:1236-40.
11. McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, et a ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol.2015;130:1-12.
12. Liu X, Li J, Lin S, Xiao X, Luo J, Wei W, et al. Evaluation of the genetic association between early-onset primary angle-closure glaucoma and retinitis pigmentosa. Exp Eye Res. 2020;197:108118.
13. Testa F, Melillo P, Rossi S, Marcelli V, de Benedictis A, Colucci R, et al. Prevalence of macular abnormalities assessed by optical coherence tomography in patients with Usher syndrome. Ophthalmic Genet.2018; 39:17-21.
14. Sayadi J, Miere A, Souied EH, et al. Type 3 Neovascularization Associated with Retinitis Pigmentosa. Case REP Ophthalmol. 2017;8:245-249.
15. Xiao W, Chen X, Yan W, Zhu Z, He M. Prevalence and risk factors of epiretinal membranes: a systematic review and meta-analysis of population-based studies. BMJ Open. 2017; 7(9):e014644.
16. Meuer SM, Myers CE, Klein BE, Swift MK, Huang Y, Gangaputra S, et al. The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Ophthalmology. 2015;122(4):787-95.
17. McCannel CA, Ensminger JL, Diehl NN, Hodge DN. Population Based Incidence of Macular Holes. Ophthalmology. 2009;116(7):1366-1369.
18. Yang MC, Chen YP, Tan EC, Leteneux C, Chang E, Chu CH, et al. Epidemiology, treatment pattern and health care utilization of myopic choroidal neovascularization: a population based study. Jpn J Ophthalmol. 2017;61(2):159-168.
19. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-809.
20. Strong S, Liew G, Michaelides M. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention. Br J Ophthalmol.2017;101:31-37.
21. Liu G, Liu X, Li H, Du Q, Wang F. Optical Coherence Tomographic Analysis of Retina in Retinitis Pigmentosa Patients. Ophthalmic Res.2016:56:111-22.
22. Fujiwara K, Ikeda Y, Murakami Y, Nakatake S, Tachibana T, Yoshida N, et al.Association Between Aqueous Flare and Epiretinal Membrane in Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2016;57:4282-6.
23. Al Rashaed S, KhanAO, NowilatySR, Edward DP ,Kozak I. Spectral-domain optical coherence tomography reveals prelaminar membranes in optic nerve head pallor in eyes with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2016; 254(1):77-81.
24. Sandberg MA, Brockhurst RJ, Gaudio AR,Berson EL. The Association between Visual Acuity and Central Retinal Thickness in Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2005;46:3349-54.
25. Yoshida N, Ikeda Y, Murakami Y, Nakatake S, Fujiwara K, Notomi S, et al. Factors Affecting Visual Acuity after Cataract Surgery in Patients with Retinitis Pigmentosa. Ophthalmology.2015;122:903-8.
26. Battaglia Parodi M, De Benedetto U, Knutsson KA, Scotti F, Librando A, Bandello F, et al. Juxtafoveal Choroidal Neovascularization Associated with Retinitis Pigmentosa Treated with Intravitreal Bevacizumab. J Ocul Pharmacol. 2012;28:202-4.
27. Bakthavatchalam M, Lai FHP, Rong SS, Ng DS, Brelen ME. Treatment of cystoid macular edema secondary to retinitis pigmentosa: A systematic review. Surv Ophthalmol. 2017;63(3):329-39.
28. Grover S, Fishman GA, Fiscella RG, Adelman AE. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina. 1997;17(3):222-31.
29. Newsome DA, Blacharski PA. Grid photocoagulation for macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1987;103(2):161-6.
30. Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H. Intravitreal Ranibizumab in the Treatment of Cystoid Macular Edema Associated with Retinitis Pigmentosa. J Ocul Pharmacol Ther. 2009;25(6):545-50.
31. García-ArumíJ, Martinez V, Sararols L, Corcostegui B. Vitreoretinal Surgery for Cystoid Macular Edema Associated with Retinitis Pigmentosa. Ophthalmology. 2003;110(6):1164-9.
32, Hashemi H, Pakzad R, Yekta A, Aghamirsalim M, Pakbin M, Ramin S, et al. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Eye (Lond). 2020;34(8):1357-1370.
33. Lee SH, Yu HG, Seo JM, Moon SW, Moon JW, Kim SJ, et al. Hereditary and Clinical Features of Retinitis Pigmentosa in Koreans. J Korean Med Sci. 2010;25:918-23.
34. Dikopf MS, Chow CC, Mieler WF, Tu EY. Cataract Extraction Outcomes and the Prevalence of Zonular Insufficiency in Retinitis Pigmentosa. Am J Ophthalmol. 2013;156:82-88.
35. Fujiwara K, Ikeda Y, Murakami Y, Funatsu J, Nakatake S, Tachibana T, et al. Risk Factors for Posterior Subcapsular Cataract in Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2017;58:2534-2537.
36. Fernández-Martínez L, Letteboer S, Mardin CY, Weisschuh N, Gramer E, Weber BH, et al. Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma. Eur J Hum Genet. 2011;19:445-51.
37. Ko YC, Liu CJ, Hwang DK, Chen TJ, Liu CJ. Increased Risk of Acute Angle Closure in Retinitis Pigmentosa: A Population-Based Case-Control Study. PLoS One. 2014; 9:e107660.
38. Eballe AO, Koki G, Emche CB, Bella LA, Kouam JM, Melong J. Blindness and visual impairment in retinitis pigmentosa: a Cameroonian hospital-based study. Clin Ophthalmol. 2010;4:661-5.